110 related articles for article (PubMed ID: 15257564)
21. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?
Goyal A; Blazing M
Am Heart J; 2005 Oct; 150(4):650-1. PubMed ID: 16209959
[No Abstract] [Full Text] [Related]
22. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
Miller M; Zhan M; Havas S
Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
[TBL] [Abstract][Full Text] [Related]
23. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease.
Khor LL; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Maycock CA; Anderson JL;
Am J Med; 2004 Nov; 117(9):657-64. PubMed ID: 15501203
[TBL] [Abstract][Full Text] [Related]
24. Association of educational level with inflammatory markers in the Framingham Offspring Study.
Loucks EB; Sullivan LM; Hayes LJ; D'Agostino RB; Larson MG; Vasan RS; Benjamin EJ; Berkman LF
Am J Epidemiol; 2006 Apr; 163(7):622-8. PubMed ID: 16421236
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein measurement and cardiovascular disease.
Wald DS; Bestwick JP
Lancet; 2010 Mar; 375(9720):1077; author reply 1077-8. PubMed ID: 20346802
[No Abstract] [Full Text] [Related]
26. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
27. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
[TBL] [Abstract][Full Text] [Related]
29. Re: "plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies".
Meerwaldt R; Links T; Zeebregts C; Smit A
Am J Epidemiol; 2008 Mar; 167(6):756-7. PubMed ID: 18296707
[No Abstract] [Full Text] [Related]
30. [High sensivity C-reactive protein as a complement to classical methods in the evaluation of coronary event's risk].
Markuszewski L; Pietruszyński R; Wojdyn M; Retelewska W
Pol Merkur Lekarski; 2006 Apr; 20(118):448-52. PubMed ID: 16886574
[TBL] [Abstract][Full Text] [Related]
31. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes.
Miller GE; Freedland KE; Duntley S; Carney RM
Am J Cardiol; 2005 Feb; 95(3):317-21. PubMed ID: 15670537
[TBL] [Abstract][Full Text] [Related]
32. Homocysteine in relation to C-reactive protein and low-density lipoprotein cholesterol in assessment of cardiovascular risk.
Herrmann W; Obeid R; Hübner U; Jouma M; Geisel J
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):895-901. PubMed ID: 15704253
[TBL] [Abstract][Full Text] [Related]
33. The influence of physiological and surgical menopause on coronary heart disease risk markers.
Verhoeven MO; van der Mooren MJ; Teerlink T; Verheijen RH; Scheffer PG; Kenemans P
Menopause; 2009; 16(1):37-49. PubMed ID: 18791484
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers of outcome from cardiovascular disease.
Khuseyinova N; Koenig W
Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein concentrations are lower in Singaporeans: implications for risk classification in Asians.
Hawkins RC
Clin Chim Acta; 2004 Dec; 350(1-2):241-2. PubMed ID: 15530485
[No Abstract] [Full Text] [Related]
37. Why does C-reactive protein predict coronary events?
Kushner I; Elyan M
Am J Med; 2008 Jul; 121(7):e11. PubMed ID: 18589040
[No Abstract] [Full Text] [Related]
38. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
39. [Related inflammation markers among different types of coronary heart disease].
Luo Y; Xie XM; Liu HX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):227-9. PubMed ID: 16145923
[TBL] [Abstract][Full Text] [Related]
40. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
